Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun-Jae | - |
dc.contributor.author | Oh, Mi-Sun | - |
dc.contributor.author | Kim, Jong S. | - |
dc.contributor.author | Chang, Dae-Il | - |
dc.contributor.author | Park, Jong-Ho | - |
dc.contributor.author | Cha, Jae-Kwan | - |
dc.contributor.author | Heo, Ji Hoe | - |
dc.contributor.author | Sohn, Sung-Il | - |
dc.contributor.author | Kim, Dong-Eog | - |
dc.contributor.author | Kim, Hahn Young | - |
dc.contributor.author | Kim, Jei | - |
dc.contributor.author | Seo, Woo-Keun | - |
dc.contributor.author | Lee, Jun | - |
dc.contributor.author | Park, Sang-Won | - |
dc.contributor.author | Kim, Yun Joong | - |
dc.contributor.author | Lee, Byung-Chul | - |
dc.date.accessioned | 2021-09-02T14:50:29Z | - |
dc.date.available | 2021-09-02T14:50:29Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 0022-3050 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77298 | - |
dc.description.abstract | Objective Selective serotonin reuptake inhibitors (SSRIs) putatively improve neurological recovery after stroke. We aimed to investigate whether serotonin transporter (SERT) gene polymorphisms are related to the responsiveness to SSRIs in the poststroke neurological recovery. Methods This was a post hoc analysis of the EMOTION study (ClinicalTrials.govNCT01278498), a randomised, placebo-controlled, double-blind trial examining the efficacy of escitalopram on emotional and neurological disturbances after acute stroke. Patients with no/minimal disability initially (modified Rankin Scale (mRS) 0-1) were excluded. Of the participants, 301 underwent genetic studies of the STin2 (a variable number tandem repeat (VNTR) in intron 2) (STin2 12/10 and STin2 12/12 genotypes) and 5-HTTLPR (a variable-length repeat in the promoter region) polymorphisms of SERT. We explored whether neurological function (National Institutes of Health Stroke Scale (NIHS) score and mRS) at 3 months would differ according to SERT polymorphisms within each treatment arm (escitalopram and placebo). Results Among the escitalopram users (n=159), neurological function in subjects with STin2 12/10 (n=29) improved significantly more than that in STin2 12/12 carriers (n=130) at 3 months. After adjusting for age, initial NIHS and depression, STin2 12/10 independently predicted a good clinical outcome (mRS 0-1) (OR 2.99, 95% CI 1.04 to 8.58) at 3 months. However, differences between STin2 polymorphisms were not shown in the placebo group (n=142). 5-HTTLPR polymorphisms were not associated with neurological recovery in any treatment group. Conclusion STin2 VNTR polymorphisms may be associated with poststroke neurological recovery after SSRI therapy. Further studies are needed to identify the role of serotonin in neurological recovery after stroke. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BMJ PUBLISHING GROUP | - |
dc.subject | AFFECTIVE-DISORDERS | - |
dc.subject | HIPPOCAMPAL NEUROGENESIS | - |
dc.subject | VARIABLE NUMBER | - |
dc.subject | ISCHEMIC-STROKE | - |
dc.subject | DEPRESSION | - |
dc.subject | FLUOXETINE | - |
dc.subject | ANTIDEPRESSANTS | - |
dc.subject | INTRON-2 | - |
dc.subject | REPEAT | - |
dc.subject | STIN2 | - |
dc.title | Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Woo-Keun | - |
dc.identifier.doi | 10.1136/jnnp-2017-316882 | - |
dc.identifier.scopusid | 2-s2.0-85042882639 | - |
dc.identifier.wosid | 000427409200009 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, v.89, no.3, pp.271 - 276 | - |
dc.relation.isPartOf | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | - |
dc.citation.title | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | - |
dc.citation.volume | 89 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 271 | - |
dc.citation.endPage | 276 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | AFFECTIVE-DISORDERS | - |
dc.subject.keywordPlus | HIPPOCAMPAL NEUROGENESIS | - |
dc.subject.keywordPlus | VARIABLE NUMBER | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | DEPRESSION | - |
dc.subject.keywordPlus | FLUOXETINE | - |
dc.subject.keywordPlus | ANTIDEPRESSANTS | - |
dc.subject.keywordPlus | INTRON-2 | - |
dc.subject.keywordPlus | REPEAT | - |
dc.subject.keywordPlus | STIN2 | - |
dc.subject.keywordAuthor | genedepression | - |
dc.subject.keywordAuthor | motor recovery | - |
dc.subject.keywordAuthor | serotonin | - |
dc.subject.keywordAuthor | stroke | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.